Accueil>>Signaling Pathways>> GPCR/G protein>> Cannabinoid Receptor>>Arachidonoyl 2'-Chloroethylamide

Arachidonoyl 2'-Chloroethylamide (Synonyms: ACEA, 2'chloroAEA)

Catalog No.GC18435

A potent and selective CB1 receptor agonist

Products are for research use only. Not for human use. We do not sell to patients.

Arachidonoyl 2'-Chloroethylamide Chemical Structure

Cas No.: 220556-69-4

Taille Prix Stock Qté
5mg
56,00 $US
En stock
10mg
100,00 $US
En stock
25mg
234,00 $US
En stock
50mg
412,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Arachidonoyl 2-chloroethylamide (ACEA) is a potent and selective cannabinoid (CB) receptor 1 agonist with Ki values of 1.4 and >2,000 nM for CB1 and CB2 receptors, respectively. In whole animal experiments, ACEA induces hypothermia in mice with the same efficacy as arachidonoyl ethanolamide , in spite of its higher affinity for the CB1 receptor. These data have been interpreted to indicate that ACEA may be a substrate for fatty acid amide hydrolase (FAAH), and thus only transiently available in whole animal experiments.

References:
[1].Pertwee, R.G. Pharmacology of cannabinoid receptor ligands Curr. Med. Chem. 6(8), 635-664 (1999).
[2].Hillard, C.J., Manna, S., Greenberg, M.J., et al. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) J. Pharmacol. Exp. Ther. 289(3), 1427-1433 (1999).

Avis

Review for Arachidonoyl 2'-Chloroethylamide

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Arachidonoyl 2'-Chloroethylamide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.